Pasithea Therapeutics Corp (KTTA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $17.44M
Last updated: Nov 17, 2026 at 11:02 AM ET
Pasithea Therapeutics Corp (KTTA) Earnings: Report Dates and Results
Pasithea Therapeutics (KTTA) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Pasithea Therapeutics reported EPS of -$0.20, above the -$0.21 estimate. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
KTTA has an expected report date of Mar 29, 2027.
Earnings History
Of the 13 quarters below that had an estimate, KTTA beat 6, missed 5 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 422.50% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.20 | -$0.21 | -$0.21 - -$0.21 | +4.76% | Beat | N/A | 1 | 1 up, 0 down | Nov 13, 2026 | N/A |
| Jun 30, 2026 | -$0.16 | -$0.16 | -$0.16 - -$0.16 | 0.00% | In line | N/A | 1 | 1 up, 0 down | Aug 14, 2026 | N/A |
| Mar 31, 2026 | -$0.12 | -$0.45 | -$0.45 - -$0.45 | +73.33% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2026 | N/A |
| Dec 31, 2025 | -$0.89 | -$0.18 | N/A | -394.44% | Miss | N/A | N/A | N/A | Feb 25, 2026 | N/A |
| Sep 30, 2025 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.66 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$1.61 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2025 | N/A |
| Dec 31, 2024 | -$2.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 24, 2025 | $649028 |
| Sep 30, 2024 | -$2.87 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2024 | N/A |
| Jun 30, 2024 | -$3.71 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2024 | N/A |
| Mar 31, 2024 | -$3.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2024 | N/A |
| Dec 31, 2023 | -$4.85 | -$3.80 | N/A | -27.54% | Miss | N/A | N/A | 0 up, 1 down | Mar 28, 2024 | $976306 |
| Sep 30, 2023 | -$0.14 | -$0.18 | N/A | +20.22% | Beat | N/A | N/A | 0 up, 1 down | Dec 29, 2023 | N/A |
| Jun 30, 2023 | -$2.84 | -$3.40 | N/A | +16.47% | Beat | N/A | N/A | N/A | Aug 11, 2023 | N/A |
| Mar 31, 2023 | -$2.47 | -$3.40 | N/A | +27.35% | Beat | N/A | N/A | N/A | May 12, 2023 | N/A |
| Dec 31, 2022 | -$0.18 | -$0.18 | N/A | 0.00% | In line | -250.0% | N/A | N/A | Mar 30, 2023 | $240712 |
| Sep 30, 2022 | -$3.20 | -$2.80 | N/A | -14.29% | Miss | N/A | N/A | 0 up, 0 down | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$2.63 | -$2.20 | N/A | -19.55% | Miss | N/A | N/A | 0 up, 0 down | Aug 15, 2022 | N/A |
| Mar 31, 2022 | -$2.09 | -$0.40 | N/A | -422.50% | Miss | N/A | N/A | 0 up, 0 down | May 16, 2022 | N/A |
| Dec 31, 2021 | $0.12 | -$0.05 | -$0.05 - -$0.05 | +340.00% | Beat | N/A | 1 | 0 up, 0 down | Mar 30, 2022 | $15062 |
| Sep 30, 2021 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 18, 2021 | N/A |
| Jun 30, 2021 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 16, 2021 | N/A |
| Mar 31, 2021 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2021 | N/A |
| Dec 31, 2020 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | N/A |
| Jun 30, 2020 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 | N/A |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$3.57, after -$12.81 the year before. It was -$0.07 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$3.57 | N/A |
| Dec 31, 2024 | -$12.81 | N/A |
| Dec 31, 2023 | -$10.30 | N/A |
| Dec 31, 2022 | -$8.10 | N/A |
| Dec 31, 2021 | -$0.14 | N/A |
| Dec 31, 2020 | -$0.07 | N/A |
Frequently Asked Questions About KTTA
When is Pasithea Therapeutics's next earnings date?
Pasithea Therapeutics's next earnings report is expected for Mar 29, 2027.
Did KTTA beat earnings estimates last quarter?
Yes. Pasithea Therapeutics reported EPS of -$0.20 for the quarter ended Sep 30, 2026, above the -$0.21 estimate, a 4.76% surprise.
What EPS do analysts expect from KTTA next quarter?
The consensus EPS estimate for Pasithea Therapeutics for the quarter ending Dec 31, 2026 is -$0.26 from 3 analysts.
How often does KTTA beat earnings estimates?
Pasithea Therapeutics beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of -34.98%.
KTTA pages: Overview, Earnings, Forecast, Financials, Competitors